IceCure Medical Ltd. Ordinary Shares – Quartalsabschluss (NASDAQ:ICCM) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Market Capitalization 25.59 M
Employee 66
Founded N/A
CEO Eyal Shamir
Website www.icecure-medical.com
Headquarter Israel
FIGI UNKNOWN
Industry Technology

Gesamtumsatz

Jahresüberschuss

Gesamtverschuldung

Freier Cashflow

Zahlungsmittel und Zahlungsmitteläquivalente

25.59 M Marktkapitalisierung

Nachrichten

IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript

IceCure Medical schedules special shareholder meeting for January 2026

Nvidia, Target, TJX, and more set to report earnings Wednesday

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Acadia Healthcare (ACHC) Beats Q3 Earnings and Revenue Estimates

IceCure Medical: Positive Studienergebnisse zur Kryoablation lassen Aktie steigen

IceCure Medical stock jumps after cryoablation study shows improved survival rates

Freezing Cancer With IceCure: ProSense Cryoablation System Receives FDA Marketing Authorization For Early-Stage Breast Cancer Treatment - Icecure Medical (NASDAQ:ICCM)

IceCure Medical: H.C. Wainwright hebt Kursziel nach FDA-Zulassung auf 2,50 US-Dollar an

IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright

IceCure Medical Ltd (ICCM) U.S. FD&A's MarketingAuthorizationforProSenseCryoablation Call

ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment